Adolescents' experience of living with X-linked hypophosphataemia (XLH): a mixed-methods analysis of those who continued and discontinued burosumab treatment after end of skeletal growth. - Saraff V; Arango-Sancho P; Bacchetta J; Boot AM; Burren CP; Chinoy A; Dharmaraj P; Gómez Llorente MA; González Rodríguez JD; Gueorguieva I; Hayes W; Schnabel D; et al. (Orphanet journal of rare diseases, 2026)